|
Originally published In Press as doi:10.1194/jlr.R400004-JLR200 on May 16, 2004
Journal of Lipid Research, Vol. 45, 1375-1397, August 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology
Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal
John M. Dietschy1 and
Stephen D. Turley
Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas, TX 75390-8887
1 To whom correspondence should be addressed. e-mail: john.dietschy{at}utsouthwestern.edu
Unesterified cholesterol is an essential structural component of the plasma membrane of every cell. During evolution, this membrane came to play an additional, highly specialized role in the central nervous system (CNS) as the major architectural component of compact myelin. As a consequence, in the human the mean concentration of unesterified cholesterol in the CNS is higher than in any other tissue ( 23 mg/g). Furthermore, even though the CNS accounts for only 2.1% of body weight, it contains 23% of the sterol present in the whole body pool. In all animals, most growth and differentiation of the CNS occurs in the first few weeks or years after birth, and the cholesterol required for this growth apparently comes exclusively from de novo synthesis. Currently, there is no evidence for the net transfer of sterol from the blood into the brain or spinal cord. In adults, the rate of synthesis exceeds the need for new structural sterol, so that net movement of cholesterol out of the CNS must take place. At least two pathways are used for this excretory process, one of which involves the formation of 24(S)-hydroxycholesterol.
Whether or not changes in the plasma cholesterol concentration alter sterol metabolism in the CNS or whether such changes affect cognitive function in the brain or the incidence of dementia remain uncertain at this time.
Abbreviations: ABC, ATP binding cassette; apoE, apolipoprotein E; CNS, central nervous system; kcal, kilocalories; LDL-C, cholesterol carried in low density lipoprotein; LDLR, LDL receptor; LRP, LDLR-related protein; LXRß, liver X receptor-ß; NPC1, Niemann-Pick C1; NPC2, Niemann-Pick C2; NPC1L1, Niemann-Pick C1-like 1; PNS, peripheral nervous system; SR-BI, scavenger receptor class B type I; SREBP, sterol-regulatory element binding protein; TC, total cholesterol Supplementary key words Alzheimer's disease amyloid precursor protein oxysterols dementia amyloid ß peptide blood-brain barrier apolipoprotein E apolipoprotein A-I lipoprotein transporters ATP binding cassette transporters

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. J. G. Schiepers, R. H. M. de Groot, M. P. J. van Boxtel, J. Jolles, A. de Jong, D. Lutjohann, J. Plat, and R. P. Mensink
Consuming Functional Foods Enriched with Plant Sterol or Stanol Esters for 85 Weeks Does Not Affect Neurocognitive Functioning or Mood in Statin-Treated Hypercholesterolemic Individuals
J. Nutr.,
July 1, 2009;
139(7):
1368 - 1373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Saher, S. Quintes, W. Mobius, M. C. Wehr, E.-M. Kramer-Albers, B. Brugger, and K.-A. Nave
Cholesterol Regulates the Endoplasmic Reticulum Exit of the Major Membrane Protein P0 Required for Peripheral Myelin Compaction
J. Neurosci.,
May 13, 2009;
29(19):
6094 - 6104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Karasinska, F. Rinninger, D. Lutjohann, P. Ruddle, S. Franciosi, J. K. Kruit, R. R. Singaraja, V. Hirsch-Reinshagen, J. Fan, L. R. Brunham, et al.
Specific Loss of Brain ABCA1 Increases Brain Cholesterol Uptake and Influences Neuronal Structure and Function
J. Neurosci.,
March 18, 2009;
29(11):
3579 - 3589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Halford and D. W. Russell
Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan
PNAS,
March 3, 2009;
106(9):
3502 - 3506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Leoni, C. Mariotti, S. J. Tabrizi, M. Valenza, E. J. Wild, S. M. D. Henley, N. Z. Hobbs, M. L. Mandelli, M. Grisoli, I. Bjorkhem, et al.
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease
Brain,
November 1, 2008;
131(11):
2851 - 2859.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Benarroch
Brain cholesterol metabolism and neurologic disease
Neurology,
October 21, 2008;
71(17):
1368 - 1373.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Li, S. D. Turley, B. Liu, J. J. Repa, and J. M. Dietschy
GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice
J. Lipid Res.,
August 1, 2008;
49(8):
1816 - 1828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kontush and M. J. Chapman
HDL: Close to Our Memories?
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2008;
28(8):
1418 - 1420.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sura, R. Sura, A. E. EnayetAllah, and D. F. Grant
Distribution and Expression of Soluble Epoxide Hydrolase in Human Brain
J. Histochem. Cytochem.,
June 1, 2008;
56(6):
551 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lyly, S. K. Marjavaara, A. Kyttala, K. Uusi-Rauva, K. Luiro, O. Kopra, L. O. Martinez, K. Tanhuanpaa, N. Kalkkinen, A. Suomalainen, et al.
Deficiency of the INCL protein Ppt1 results in changes in ectopic F1-ATP synthase and altered cholesterol metabolism
Hum. Mol. Genet.,
May 15, 2008;
17(10):
1406 - 1417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Wang, L. Yvan-Charvet, D. Lutjohann, M. Mulder, T. Vanmierlo, T.-W. Kim, and A. R. Tall
ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain
FASEB J,
April 1, 2008;
22(4):
1073 - 1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ponce, N. P. de la Ossa, O. Hurtado, M. Millan, J. F. Arenillas, A. Davalos, and T. Gasull
Simvastatin Reduces the Association of NMDA Receptors to Lipid Rafts: A Cholesterol-Mediated Effect in Neuroprotection
Stroke,
April 1, 2008;
39(4):
1269 - 1275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Manzi, A. L. Loizzo, G. Giana, and P. Curatolo
Autism and Metabolic Diseases
J Child Neurol,
March 1, 2008;
23(3):
307 - 314.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Pond, H. J. Mersmann, D. Su, J. J. McGlone, M. B. Wheeler, and E. O. Smith
Neonatal Dietary Cholesterol and Alleles of Cholesterol 7-{alpha} Hydroxylase Affect Piglet Cerebrum Weight, Cholesterol Concentration, and Behavior
J. Nutr.,
February 1, 2008;
138(2):
282 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Carter, L. Demizieux, R. B. Campenot, D. E. Vance, and J. E. Vance
Phosphatidylcholine Biosynthesis via CTP:Phosphocholine Cytidylyltransferase 2 Facilitates Neurite Outgrowth and Branching
J. Biol. Chem.,
January 4, 2008;
283(1):
202 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Repa, H. Li, T. C. Frank-Cannon, M. A. Valasek, S. D. Turley, M. G. Tansey, and J. M. Dietschy
Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse
J. Neurosci.,
December 26, 2007;
27(52):
14470 - 14480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Cao, H. Lu, T. L. Lewis, and L. Li
Intake of Sucrose-sweetened Water Induces Insulin Resistance and Exacerbates Memory Deficits and Amyloidosis in a Transgenic Mouse Model of Alzheimer Disease
J. Biol. Chem.,
December 14, 2007;
282(50):
36275 - 36282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-S. Hoe, M. J. Cooper, M. P. Burns, P. A. Lewis, M. van der Brug, G. Chakraborty, C. M. Cartagena, D. T. S. Pak, M. R. Cookson, and G. W. Rebeck
The Metalloprotease Inhibitor TIMP-3 Regulates Amyloid Precursor Protein and Apolipoprotein E Receptor Proteolysis
J. Neurosci.,
October 3, 2007;
27(40):
10895 - 10905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pertusa, C. Morenilla-Palao, C. Carteron, F. Viana, and H. Cabedo
Transcriptional Control of Cholesterol Biosynthesis in Schwann Cells by Axonal Neuregulin 1
J. Biol. Chem.,
September 28, 2007;
282(39):
28768 - 28778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Valenza, J. B. Carroll, V. Leoni, L. N. Bertram, I. Bjorkhem, R. R. Singaraja, S. Di Donato, D. Lutjohann, M. R. Hayden, and E. Cattaneo
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation
Hum. Mol. Genet.,
September 15, 2007;
16(18):
2187 - 2198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-i. Ito, Y. Nagayasu, K. Okumura-Noji, R. Lu, T. Nishida, Y. Miura, K. Asai, A. Kheirollah, S. Nakaya, and S. Yokoyama
Mechanism for FGF-1 to regulate biogenesis of apoE-HDL in astrocytes
J. Lipid Res.,
September 1, 2007;
48(9):
2020 - 2027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Liu, C. Xie, J. A. Richardson, S. D. Turley, and J. M. Dietschy
Receptor-mediated and bulk-phase endocytosis cause macrophage and cholesterol accumulation in Niemann-Pick C disease
J. Lipid Res.,
August 1, 2007;
48(8):
1710 - 1723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn
Genomic Profiling in Nuclear Receptor-Mediated Toxicity
Toxicol Pathol,
June 1, 2007;
35(4):
474 - 494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Guizzetti and L. Costa
Cholesterol homeostasis in the developing brain: a possible new target for ethanol
Human and Experimental Toxicology,
April 1, 2007;
26(4):
355 - 360.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Beltroy, B. Liu, J. M. Dietschy, and S. D. Turley
Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann-Pick type C disease
J. Lipid Res.,
April 1, 2007;
48(4):
869 - 881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Karu, M. Hornshaw, G. Woffendin, K. Bodin, M. Hamberg, G. Alvelius, J. Sjovall, J. Turton, Y. Wang, and W. J. Griffiths
Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols
J. Lipid Res.,
April 1, 2007;
48(4):
976 - 987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Meaney, M. Heverin, U. Panzenboeck, L. Ekstrom, M. Axelsson, U. Andersson, U. Diczfalusy, I. Pikuleva, J. Wahren, W. Sattler, et al.
Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7{alpha}-hydroxy-3-oxo-4-cholestenoic acid
J. Lipid Res.,
April 1, 2007;
48(4):
944 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hayashi, R. B. Campenot, D. E. Vance, and J. E. Vance
Apolipoprotein E-Containing Lipoproteins Protect Neurons from Apoptosis via a Signaling Pathway Involving Low-Density Lipoprotein Receptor-Related Protein-1
J. Neurosci.,
February 21, 2007;
27(8):
1933 - 1941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sugii, S. Lin, N. Ohgami, M. Ohashi, C. C. Y. Chang, and T.-Y. Chang
Roles of Endogenously Synthesized Sterols in the Endocytic Pathway
J. Biol. Chem.,
August 11, 2006;
281(32):
23191 - 23206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Xie, J. A. Richardson, S. D. Turley, and J. M. Dietschy
Cholesterol substrate pools and steroid hormone levels are normal in the face of mutational inactivation of NPC1 protein
J. Lipid Res.,
May 1, 2006;
47(5):
953 - 963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Kotti, D. M. O. Ramirez, B. E. Pfeiffer, K. M. Huber, and D. W. Russell
Brain cholesterol turnover required for geranylgeraniol production and learning in mice
PNAS,
March 7, 2006;
103(10):
3869 - 3874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Thelen, K. M. Rentsch, U. Gutteck, M. Heverin, M. Olin, U. Andersson, A. von Eckardstein, I. Bjorkhem, and D. Lutjohann
Brain Cholesterol Synthesis in Mice Is Affected by High Dose of Simvastatin but Not of Pravastatin
J. Pharmacol. Exp. Ther.,
March 1, 2006;
316(3):
1146 - 1152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ohyama, S. Meaney, M. Heverin, L. Ekstrom, A. Brafman, M. Shafir, U. Andersson, M. Olin, G. Eggertsen, U. Diczfalusy, et al.
Studies on the Transcriptional Regulation of Cholesterol 24-Hydroxylase (CYP46A1): MARKED INSENSITIVITY TOWARD DIFFERENT REGULATORY AXES
J. Biol. Chem.,
February 17, 2006;
281(7):
3810 - 3820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bartzokis, P. H. Lu, D. H. Geschwind, N. Edwards, J. Mintz, and J. L. Cummings
Apolipoprotein E Genotype and Age-Related Myelin Breakdown in Healthy Individuals: Implications for Cognitive Decline and Dementia
Arch Gen Psychiatry,
January 1, 2006;
63(1):
63 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Koldamova, M. Staufenbiel, and I. Lefterov
Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice
J. Biol. Chem.,
December 30, 2005;
280(52):
43224 - 43235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A Woollett
Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation
Am. J. Clinical Nutrition,
December 1, 2005;
82(6):
1155 - 1161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-Y. Chang, P. C. Reid, S. Sugii, N. Ohgami, J. C. Cruz, and C. C. Y. Chang
Niemann-Pick Type C Disease and Intracellular Cholesterol Trafficking
J. Biol. Chem.,
June 3, 2005;
280(22):
20917 - 20920.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Keller, M. Small, and S. J. Fliesler
Enzyme blockade: a nonradioactive method to determine the absolute rate of cholesterol synthesis in the brain
J. Lipid Res.,
October 1, 2004;
45(10):
1952 - 1957.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|